Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 9;12(6):759.
doi: 10.3390/brainsci12060759.

Nomogram to Predict Cognitive State Improvement after Deep Brain Stimulation for Parkinson's Disease

Affiliations

Nomogram to Predict Cognitive State Improvement after Deep Brain Stimulation for Parkinson's Disease

Bowen Chang et al. Brain Sci. .

Abstract

Purpose: Parkinson's disease (PD) is a common neurodegenerative disease, for which cognitive impairment is a non-motor symptom (NMS). Bilateral subthalamic nucleus deep brain stimulation (STN-DBS) is an effective treatment for PD. This study established a nomogram to predict cognitive improvement rate after STN-DBS in PD patients.

Methods: We retrospectively analyzed 103 PD patients who underwent STN-DBS. Patients were followed up to measure improvement in MoCA scores one year after surgery. Univariate and multivariate logistic regression analyses were used to identify factors affecting improvement in cognitive status. A nomogram was developed to predict this factor. The discrimination and fitting performance were evaluated by receiver operating characteristics (ROC) analysis, calibration diagram, and decision curve analysis (DCA).

Results: Among 103 patients, the mean improvement rate of the MoCA score was 37.3% and the median improvement rate was 27.3%, of which 64% improved cognition, 27% worsened cognition, and 8.7% remained unchanged. Logistic multivariate regression analysis showed that years of education, UPDRSIII drug use, MoCA Preop, and MMSE Preop scores were independent factors affecting the cognitive improvement rate. A nomogram model was subsequently developed. The C-index of the nomogram was 0.98 (95%CI, 0.97-1.00), and the area under the ROC was 0.98 (95%CI 0.97-1.00). The calibration plot and DCA demonstrated the goodness-of-fit between nomogram predictions and actual observations.

Conclusion: Our nomogram could effectively predict the possibility of achieving good cognitive improvement one year after STN-DBS in patients with PD. This model has value in judging the expected cognitive improvement of patients with PD undergoing STN-DBS.

Keywords: Parkinson’s disease; cognitive state; deep brain stimulation; nomogram; non-motor symptoms.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.

Figures

Figure 1
Figure 1
Comparison of MoCA score between pre-operation and one year after operation.
Figure 2
Figure 2
Comparison of details of MoCA score between preoperative and postoperative one year. ** p < 0.01.
Figure 3
Figure 3
Correlations of MoCA score improvement rate with MoCA preop (A), education (B), MMSE preop (C) and UPDRSIII drug on (D).
Figure 4
Figure 4
Nomogram to predict improvement of MoCA score after STN-DBS for PD. Clinical factor corresponds to a specific point by drawing a line straight upward to the points axis. After the sum of the points is located on the total points axis, the sum represents the probability of obtaining higher a MoCA score improvement rate. * p < 0.01, *** p < 0.001.
Figure 5
Figure 5
A receiver operating characteristic curve to evaluate the discriminating capability of the nomogram.
Figure 6
Figure 6
Calibration curve of the model. The calibration of the model in line with the agreement between predicted and observed outcomes of improvement of MoCA score.
Figure 7
Figure 7
The decision curve analysis diagram of the model.

Similar articles

Cited by

References

    1. Cerri S., Mus L., Blandini F. Parkinson’s Disease in Women and Men: What’s the Difference? J. Parkinsons Dis. 2019;9:501–515. doi: 10.3233/JPD-191683. - DOI - PMC - PubMed
    1. Ascherio A., Schwarzschild M.A. The epidemiology of Parkinson’s disease: Risk factors and prevention. Lancet Neurol. 2016;15:1257–1272. doi: 10.1016/S1474-4422(16)30230-7. - DOI - PubMed
    1. Ribault S., Simon E., Berthiller J., Polo G., Nunes A., Brinzeu A., Mertens P., Danaila T., Thobois S., Laurencin C. Comparison of clinical outcomes and accuracy of electrode placement between robot-assisted and conventional deep brain stimulation of the subthalamic nucleus: A single-center study. Acta Neurochir. 2021;163:1327–1333. doi: 10.1007/s00701-021-04790-7. - DOI - PubMed
    1. Pinto S., Le Bas J.F., Castana L., Krack P., Pollak P., Benabid A.L. Comparison of two techniques to postoperatively localize the electrode contacts used for subthalamic nucleus stimulation. Neurosurgery. 2007;60((Suppl. 2)):285–292. doi: 10.1227/01.NEU.0000255353.64077.A8. discussion 292–294. - DOI - PubMed
    1. Liu Y., Wu L., Yang C., Xian W., Zheng Y., Zhang C., Hong G., Jiang L., Yang Z., Pei Z., et al. The white matter hyperintensities within the cholinergic pathways and cognitive performance in patients with Parkinson’s disease after bilateral STN DBS. J. Neurol. Sci. 2020;418:117121. doi: 10.1016/j.jns.2020.117121. - DOI - PubMed

LinkOut - more resources